AFO efficacy in Cerebral Palsy.

Recruiting

• Conditions: Cerebral Palsy, Cerebrale Parese; children, kinderen; orthotic devices, orthesen; treatment outcome, behandeluitkomsten; mobility, mobiliteit

• Registration Number: NL-OMON27398
• Lead Sponsor: VU University Medical Center

Brief Summary

/A

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 32

Inclusion Criteria

Inclusion criteria for enrolling the study are:

1. Diagnosis of spastic CP;

Exclusion Criteria

1. Any orthopedic surgery or other surgical interventions that might influence mobility in the past six months;

2. Botulinum Toxin A injections in the past three months;

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Energy cost of walking (assessed with the Energy Cost of Walking Test (ECWT));<br /><br>2. The subject's daily activity (assessed with the StepWatch Activity Monitior).

Secondary Outcome Measures

Name	Time	Method
1. Gait biomechanics (assessed with 3D- gait analysis);<br /><br>2. Diversity, intensity and enjoyment of participation (assessed with CAPE);<br /><br>3. Walking speed (assessed with ECWT).